Literature DB >> 21943863

Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens.

Catherine H Roberts, Colette Smith, Ronan Breen, Radha Gadhok, Michael Murphy, Anna Aryee, Ian Cropley, Sanjay Bhagani, Susan Hopkins, Marc Lipman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21943863     DOI： 10.5588/ijtld.11.0352

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  3 in total

Review 1.  Safety and tolerability profile of second-line anti-tuberculosis medications.

Authors:  Geetha Ramachandran; Soumya Swaminathan
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

2.  Multidrug-resistant tuberculosis: Treatment and outcomes of 93 patients.

Authors:  Sarah K Brode; Robert Varadi; Jane McNamee; Nina Malek; Sharon Stewart; Frances B Jamieson; Monica Avendano
Journal:  Can Respir J       Date:  2014-12-10       Impact factor: 2.409

3.  Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea.

Authors:  Bo Hyoung Kang; Kyung-Wook Jo; Tae Sun Shim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.